Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01050504 · ClinicalTrials.gov registry record

Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer

A clinical trial of Malignant Solid Neoplasm and Recurrent Prostate Carcinoma, sponsored by University of Washington.

Recruiting
Registry status
1,500
Enrollment target
1
Study location

NCT01050504: Recruiting study of Malignant Solid Neoplasm and Recurrent Prostate Carcinoma, sponsored by University of Washington.

NCT01050504 is a study of Malignant Solid Neoplasm and Recurrent Prostate Carcinoma that is actively recruiting participants, run by University of Washington. The registered enrollment target is 1,500 participants, above the 1,132-participant average among 176 other Malignant Solid Neoplasm trials with a reported enrollment target (33% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01050504, a study of Malignant Solid Neoplasm and Recurrent Prostate Carcinoma, is actively recruiting participants, sponsored by University of Washington.

RECRUITING
Registry status
1,500 participants
Enrollment target
1
Study location

Study Summary

This study collects and studies tissue and blood samples from patients with prostate or bladder/urothelial cancer that has recurred (come back) at or near the same place as the original (primary) tumor or has spread to other parts of the body. Studying samples of blood and tissue samples from patients with prostate or bladder/urothelial cancer in the laboratory may help doctors learn more about new biomarkers, potential drug targets, and resistance developing in response to treatment. It may also help doctors find better ways to treat the cancer.

Conditions Studied

Malignant Solid Neoplasm Recurrent Prostate Carcinoma Metastatic Malignant Neoplasm in the Bone Stage IV Bladder Urothelial Carcinoma AJCC v7 Metastatic Renal Pelvis and Ureter Urothelial Carcinoma Recurrent Bladder Carcinoma Localized Renal Pelvis and Ureter Urothelial Carcinoma Metastatic Malignant Neoplasm in the Soft Tissues Stage IV Bladder Cancer AJCC v7 Recurrent Renal Pelvis and Ureter Urothelial Carcinoma

Interventions

  • OTHER Laboratory Biomarker Analysis
  • OTHER Cytology Specimen Collection Procedure

Study Locations (1)

Washington

  • Fred Hutch/University of Washington Cancer Consortium - Seattle

Trial Details

FieldValue
Enrollment Target 1,500 participants
Start Date 2009-08
Est. Completion 2029-01-31
University of Washington

1,048 total trials

What NCT01050504 shows while recruiting

NCT01050504 is an observational study that tracks outcomes without assigning an intervention. Its 1,500 participants enrollment target places it among the larger protocols in the corpus, above the 1,132-participant average among 176 other Malignant Solid Neoplasm trials with a reported enrollment target (33% higher).

The record links to 10 conditions, with Malignant Solid Neoplasm appearing as the primary indexed condition, and to 2 interventions - of which Laboratory Biomarker Analysis is the first listed.

NCT01050504 reports a single indexed study location in Washington.

Frequently Asked Questions

What is clinical trial NCT01050504 about?

NCT01050504 is a clinical study titled "Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer". This study collects and studies tissue and blood samples from patients with prostate or bladder/urothelial cancer that has recurred (come back) at or near the same place as the original (primary) tumor or has spread to other parts of the body. Studying samples of blood and tissue samples from patien...

What is the current status of trial NCT01050504?

This trial is currently recruiting. The enrollment target is 1,500 participants. The study started on 2009-08. Estimated completion is 2029-01-31.

What conditions does trial NCT01050504 study?

This clinical trial studies the following conditions: Malignant Solid Neoplasm, Recurrent Prostate Carcinoma, Metastatic Malignant Neoplasm in the Bone, Stage IV Bladder Urothelial Carcinoma AJCC v7, Metastatic Renal Pelvis and Ureter Urothelial Carcinoma.

What interventions are being tested in trial NCT01050504?

The interventions under investigation include: Laboratory Biomarker Analysis (OTHER), Cytology Specimen Collection Procedure (OTHER).

Who is sponsoring clinical trial NCT01050504?

This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01050504 being conducted?

This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Malignant Solid Neoplasm

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01050504's enrollment target sits among peer trials

1,500 17th of 176 higher than 160 of 176 other Malignant Solid Neoplasm trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Malignant Solid Neoplasm trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00178724 · 1,500 participants

    Spinal Cord Injury Registry - North American Clinical Trials Network

  • NCT00951366 · 1,500 participants

    Preterm Lung Patient Registry

  • NCT02071134 · 1,500 participants

    Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry

  • NCT02677961 · 1,500 participants

    An Electronic Health Record (EHR)-Based Comprehensive Bone and Soft Tissue Tumor Registry

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

More recruiting context for NCT01050504

Source: ClinicalTrials.gov NCT01050504, the US trial registry maintained by the National Library of Medicine. NCT01050504 (large enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.